This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (39)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Anne E. Clatworthy; Teresa Gomez-Isla, MD, PhD; G. William Rebeck, PhD; R. B. Wallace, MD; Bradley T. Hyman, MD, PhD

Arch Neurol. 1997;54(10):1289-1292.

Abstract
Background
The apolipoprotein E 4 (ApoE 4) allele is associated with an increased risk for development of Alzheimer disease (AD). We hypothesized that polymorphisms in proteins that interact with ApoE also might have an impact on the likelihood of AD developing. We examined a polymorphism in the gene for the low-density lipoprotein receptor-related protein (LRP), because LRP is a major ApoE receptor in the brain that also mediates binding and degradation of secreted Kunitz protease inhibitor forms of amyloid precursor protein.

Subjects and Design
The LRP genotypes in 2 groups were studied. The first group consisted of 130 patients with probable or definite AD (mean±SD age, 78.2±8.9 years) and 64 nondemented, control subjects (mean±SD age, 81.7±12.3 years) who were primarily the spouses of the patients. The second group consisted of individuals from a population-based, epidemiologic study, including 38 cognitively impaired individuals (mean±SD age, 79.9±4.1 years) and 93 nondemented controls (mean±SD age, 78.7±4.4 years). Finally, 22 brains with a neuropathological diagnosis of AD were evaluated for neuronal loss, β-amyloid deposition, and neurofibrillary tangle number and compared with the LRP genotype.

Results
No genetic disequilibrium in LRP allele frequencies between controls and patients with AD or cognitive impairment was observed. No interaction between the ApoE 4 and LRP genotypes was observed in patients with AD. Moreover, the LRP genotype did not correlate with degree of neuronal loss, β-amyloid deposition, or neurofibrillary tangle number in individuals examined using quantitative neuropathological techniques.

Conclusion
This LRP gene polymorphism is not linked with the pathophysiological changes of AD.

Author Affiliations
From the Department of Neurology-Alzheimer Unit, Massachusetts General Hospital, Charlestown (Ms Clatworthy and Drs Gomez-Isla, Rebeck, and Hyman), and the Department of Preventive Medicine, University of Iowa College of Medicine, Iowa City (Dr Wallace).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Neuronal Apoptosis by Apolipoprotein E4 through Low-Density Lipoprotein Receptor-Related Protein and Heterotrimeric GTPases
Hashimoto et al.
J. Neurosci. 2000;20:8401-8409.
ABSTRACT | FULL TEXT  

Role of the Low-density Lipoprotein Receptor-Related Protein in {beta}-Amyloid Metabolism and Alzheimer Disease
Hyman et al.
Arch Neurol 2000;57:646-650.
ABSTRACT | FULL TEXT